Tumor-Specific Cancer Immunotherapies

Cancer
Cancer Biopharmaceuticals
Tumor-Specific Cancer Immunotherapies

A Closer Look at Tscan Therapeutics (TCRX): Driving Advancements in TCR-T Cell Therapy for Cancer

Tscan Therapeutics Inc (TCRX) is a biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell therapies for the treatment of cancer. The company’s proprietary platform identifies novel TCR targets and engineers TCRs directed against these targets for use in TCR-T cell therapies. These therapies aim to harness the power of the […]

Read More
Cancer
Cancer Biopharmaceuticals
Tumor-Specific Cancer Immunotherapies

Innovative Cancer Treatments: How Verastem (VSTM) is Changing the Game

Verastem, Inc. (VSTM) is a biopharmaceutical company focused on the discovery, development, and commercialization of novel therapies for the treatment of cancer. The company was founded in 2010 and is headquartered in Needham, Massachusetts. Verastem’s mission is to improve the lives of patients suffering from cancer by targeting the underlying biology of cancer stem cells, […]

Read More
Biotech
Cancer
Cancer Biopharmaceuticals
Coronavirus
COVID-19
Dividends
Economy
Fibonacci Retracement
Fundamental Analysis
HeathCare
Immunology Biopharmaceutical
Immunotherapies
Pharmaceuticals
RNA Biotechnology
Technical Analysis
Tumor-Specific Cancer Immunotherapies
Vaccines
Value Investing
Value Stocks

PFE is down about 20% in the last three months, and that’s a good thing for value-focused investors

As recently as a few months ago, a lot of signs about the global pandemic seemed to suggest that the worst of the worst was over, and we could all finally begin to put COVID-19 concerns and commentary in the rear view. As contagious variants of the virus have emerged, however, it has become more […]

Read More
Cancer Biopharmaceuticals
Daily Rundown
Minimally-Invasive Medical devices
Online Talent Marketplace
Specialty Food
Tumor-Specific Cancer Immunotherapies

Cancer Biopharma, Specialty Food, Minimally-Invasive Medical devices, Tumor-Specific Cancer Immunotherapies, Online Talent Marketplace

Verastem, Inc. (VSTM) Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing medicines to enhance the life of cancer patients. Its product in development include VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) inhibitor that blocks MEK kinase activity and the ability of RAF to phosphorylate MEK. The Chefs’ Warehouse, Inc. […]

Read More